{"id":"https://openalex.org/W2503512783","doi":null,"title":"GALECTIN-3 AS A PREDICTOR OF STATIN TREATMENT EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA.","display_name":"GALECTIN-3 AS A PREDICTOR OF STATIN TREATMENT EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA.","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W2503512783","mag":"2503512783","pmid":"https://pubmed.ncbi.nlm.nih.gov/27441537"},"language":"en","primary_location":{"id":"pmid:27441537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27441537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2503512783"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034389732","display_name":"Borys B. Samura","orcid":"https://orcid.org/0000-0002-4311-1806","observed_orcids":["https://orcid.org/0000-0002-4311-1806"]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":true,"raw_author_name":"B Samura","raw_affiliation_strings":["Zaporozhye State Medical University, Zaporozhye, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University, Zaporozhye, Ukraine","institution_ids":["https://openalex.org/I2802984365"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034389732"],"corresponding_institution_ids":["https://openalex.org/I2802984365"],"apc_list":null,"apc_paid":null,"fwci":0.4606,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.63870482,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":"255","first_page":"56","last_page":"61"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.35109999775886536,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.035100001841783524,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-3","display_name":"galectin-3","score":0.9760000109672546},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.9700000286102295},{"id":"https://openalex.org/keywords/one-year-survival","display_name":"one-year survival","score":0.8849999904632568},{"id":"https://openalex.org/keywords/nt-probnp","display_name":"NT-proBNP","score":0.9039999842643738},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9779999852180481},{"id":"https://openalex.org/keywords/lipid-lowering","display_name":"lipid lowering","score":0.4880000054836273},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/treatment-effectiveness-prediction","display_name":"treatment efficacy prediction","score":0.5270000100135803},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.6650000214576721},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.6019999980926514},{"id":"https://openalex.org/keywords/cardiovascular-risk-stratification","display_name":"cardiovascular risk stratification","score":0.5249999761581421},{"id":"https://openalex.org/keywords/risk-prediction-model","display_name":"risk prediction model","score":0.34700000286102295},{"id":"https://openalex.org/keywords/remission-maintenance-therapy","display_name":"remission maintenance therapy","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8672076463699341},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.7879478931427002},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.775987982749939},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7491648197174072},{"id":"https://openalex.org/C2775846464","wikidata":"https://www.wikidata.org/wiki/Q66360952","display_name":"Brain natriuretic peptide","level":3,"score":0.5330167412757874},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.5244722366333008},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.47633033990859985},{"id":"https://openalex.org/C2775915353","wikidata":"https://www.wikidata.org/wiki/Q1571529","display_name":"Natriuretic peptide","level":3,"score":0.44561082124710083},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.435962975025177},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34969279170036316},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.222202330827713},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.1678086221218109}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D037502","descriptor_name":"Galectin 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:27441537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27441537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Georgian medical news","raw_type":"Journal Article"},{"id":"mag:2503512783","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27441537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2239812652","https://openalex.org/W4302084544","https://openalex.org/W2951028507","https://openalex.org/W2605874891","https://openalex.org/W7213950438","https://openalex.org/W3042622508","https://openalex.org/W2522190852","https://openalex.org/W2906768988","https://openalex.org/W7204696496"],"abstract_inverted_index":{"THE":[0,3],"AIM":[1],"OF":[2],"STUDY:":[4],"to":[5,106],"investigate":[6],"an":[7],"interrelationship":[8],"between":[9,163],"pre-treatment":[10,258],"galcetin-3":[11],"(Gal-3)":[12],"level":[13,122,231,254,260],"and":[14,62,81,126,160,194],"one-year":[15,206,219],"survival":[16,245,272],"rate,":[17],"cardiovascular":[18,221],"events":[19,222],"in":[20,38,55,72,135,146,158,246,273],"subjects":[21,27],"with":[22,28,140,250,275],"multiple":[23,34,247,278],"myeloma.":[24,279],"Eighty":[25],"nine":[26],"full":[29],"or":[30,50,98],"partial":[31],"remission":[32],"of":[33,88,120,123,266,269,277],"myeloma":[35,248],"were":[36,42,53,114,130,166],"enrolled":[37],"the":[39,69,73,89],"study.":[40],"Patients":[41],"divided":[43],"into":[44,234],"2":[45],"groups":[46],"based":[47],"on":[48,212,271],"whether":[49],"not":[51,147,153],"statins":[52,97,270],"included":[54],"their":[56],"treatment:":[57],"a":[58,63,263],"statin":[59,65,74,136,148,195,213,237],"group":[60,66],"(n=43)":[61],"no":[64],"(n=46).":[67],"Among":[68],"43":[70],"patients":[71,77,83,90,249,274],"group,":[75],"31":[76],"received":[78,84,92],"20mg/day":[79],"atorvastatin":[80],"12":[82],"40-mg/day":[85],"atorvastatin.":[86],"None":[87],"had":[91,171],"any":[93,156],"lipid-modulating":[94],"medications,":[95],"including":[96],"fibrates,":[99],"before":[100],"enrollment.":[101],"Observation":[102],"period":[103],"was":[104,138,152,239,261],"up":[105],"1":[107],"year.":[108],"Blood":[109],"samples":[110],"for":[111,118,243],"biomarkers":[112,162],"measurements":[113,119],"collected.":[115],"ELISA":[116],"method":[117],"circulating":[121],"galectin-3,":[124],"interleukin-6":[125],"NT-pro-brain":[127,187],"natriuretic":[128,188],"peptide":[129,189],"used.":[131],"Lipid":[132],"lowering":[133],"effect":[134,268],"user":[137],"associates":[139],"declined":[141],"serum":[142,229,252],"Gal-3":[143],"level,":[144],"whereas":[145],"users":[149],"similar":[150],"response":[151],"appeared.":[154],"No":[155],"changes":[157],"hemodynamics":[159],"other":[161],"both":[164],"cohorts":[165],"found.":[167],"Univariate":[168],"logistic":[169],"regression":[170,276],"exhibited":[172],"that":[173],"galtctin-3":[174],"(odds":[175],"ratio":[176],"[OR]":[177],"=":[178,182,185,200,203],"1.17;":[179],"95%":[180,191,198,224],"CI":[181,199],"1.07-1.29;":[183],"P":[184,202],"0.002),":[186],"(OR=1.04;":[190],"CI=1.02-1.10;":[192],"P<0.05)":[193],"therapy":[196,238],"(OR=1.07;":[197],"1.02-1.11;":[201],"0.001)":[204],"predicted":[205],"cumulative":[207,220],"CV":[208],"events.":[209],"After":[210],"adjustment":[211],"therapy,":[214],"galectin-3":[215,230,253,259],"remained":[216],"independent":[217],"predictor":[218,242,265],"(OR=1.08;":[223],"CI=1.06-1.11;":[225],"P=0.001).":[226],"When":[227],"initial":[228],"has":[232],"incorporated":[233],"prediction":[235],"model,":[236],"found":[240,262],"as":[241],"improving":[244],"elevated":[251],"(>14":[255],"ng/ml).":[256],"Elevated":[257],"powerful":[264],"positive":[267]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2503512783","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-08-23T00:00:00"}
